Results
6
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
6 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CCB | лв1.69 | 2.4% | 10.5% | лв214.8m | n/a | PB0.3x | n/a | n/a | Banks | ||
THQM New | лв17.90 | 0% | 5.3% | лв1.6b | n/a | PE326.2x | n/a | 0% | Pharmaceuticals & Biotech | ||
SPDY | лв202.00 | -2.9% | 43.3% | лв1.1b | n/a | PE25.4x | n/a | 2.8% | Transportation | ||
SFT | лв5.75 | 0% | 0.9% | лв197.0m | n/a | PE5.2x | n/a | 0% | Healthcare | ||
ATOM | лв14.50 | 0% | 20.8% | лв222.6m | n/a | PE10.1x | n/a | 0.3% | Commercial Services | ||
SLYG | €35.50 | 2.0% | 18.9% | €642.7m | €42.81 | PE31.6x | E34.6% | 0.4% | Tech |